SPRB: Spruce Biosciences, Inc. Stock

by  •  • Comments Off on SPRB: Spruce Biosciences, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 30.52
Enterprise Value ($M) -62.48
Book Value ($M) 76.51
Book Value / Share 1.86
Price / Book 0.40
NCAV ($M) 74.75
NCAV / Share 1.82
Price / NCAV 0.41

Profitability (mra)
Return on Invested Capital (ROIC) -0.59
Return on Assets (ROA) -0.34
Return on Equity (ROE) -0.44

Liquidity (mrq)
Quick Ratio 4.18
Current Ratio 4.18

Balance Sheet (mrq) ($M)
Current Assets 102.18
Assets 103.95
Liabilities 27.44
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 10.09
Operating Income -51.99
Net Income -47.92

Cash Flow Statement (mra) ($M)
Cash From Operations -33.27
Cash from Investing 55.78
Cash from Financing 49.14

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
9 days ago 13G/A Rosalind Advisors, Inc. 3.67 -35.04
03-28 13D/A Novo Holdings A/S 3.90 -39.91
03-28 13G Radoff Bradley Louis 6.90
03-07 13D/A HealthCap VIII, L.P. 8.90 0.00
02-14 13G/A Rock Springs Capital Management LP 6.41 60.79
02-14 13G Armistice Capital, Llc 5.48
02-14 13G/A Citadel Advisors Llc 0.30
02-06 13G/A Aisling Capital V, LP 3.00
05-30 13D/A RiverVest Venture Fund III, L.P. 8.60 64.19

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-03-18 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K
2023-11-13 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q
2023-08-14 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q
2023-05-15 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-05-03 87,990 469,941 18.72
2024-05-02 87,703 39,952 219.52
2024-05-01 133,719 113,087 118.24
2024-04-30 57,372 41,908 136.90
2024-04-29 48,362 36,682 131.84

(click for more detail)

Similar Companies
SLRN – Acelyrin, Inc. SNDX – Syndax Pharmaceuticals, Inc.
SOPH – SOPHiA GENETICS SA SPRO – Spero Therapeutics, Inc.
SRPT – Sarepta Therapeutics, Inc.


Financial data and stock pages provided by
Fintel.io